Xu Dong, Hou Yong, Zheng Yuanfang, Zheng Yue, Li Mengtao, Zeng Xiaofeng
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.
PLoS One. 2016 Nov 16;11(11):e0166629. doi: 10.1371/journal.pone.0166629. eCollection 2016.
To evaluate the performance of the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in clinical practice in a Chinese patient cohort, and to compare outcomes with the 1980 ACR criteria.
Patients clinically diagnosed with SSc between September 2013 and May 2015 were prospectively recruited from the EUSTAR database of the Peking Union Medical College Hospital. Diagnosis of SSc was based on the evaluation of three experienced rheumatologists. Patients diagnosed with other connective tissue diseases were recruited as disease controls. The 1980 ACR and 2013 ACR/EULAR criteria were applied to the cohort, and patients who fulfilled the criteria were classified as definite SSc patients. Sensitivity and specificity were analyzed for the 2013 and 1980 criteria.
A total of 143 SSc patients and 87 patients with other connective diseases were recruited. 41 (28.7%) and 102 (71.3%) cases were diffuse cutaneous SSc and limited cutaneous SSc, respectively. Although the sensitivity of the 2013 criteria (94.4%) exceeded the 1980 criteria (72.7%) (P<0.001), the 1980 and 2013 criteria sets showed no significant difference in specificity (97.7% and 93.1%, respectively, P = 0.278). The sensitivity of the 2013 criteria was significantly higher than the 1980 criteria in some SSc subgroups (e.g., lcSSc, abnormal pattern of nailfold videocapillaroscopy [NVC] and presence of Raynaud's phenomenon [RP]) compared to others.
Relative to the 1980 ACR criteria, in Chinese SSc patients the new 2013 ACR/EULAR criteria had similar specificity and higher sensitivity, especially for patients with mild skin thickening or prominent microvascular diseases.
评估2013年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)系统性硬化症(SSc)分类标准在中国患者队列临床实践中的表现,并与1980年ACR标准的结果进行比较。
2013年9月至2015年5月期间临床诊断为SSc的患者从北京协和医院的EUSTAR数据库中前瞻性招募。SSc的诊断基于三位经验丰富的风湿病学家的评估。诊断为其他结缔组织病的患者被招募作为疾病对照。将1980年ACR标准和2013年ACR/EULAR标准应用于该队列,符合标准的患者被分类为确诊的SSc患者。分析了2013年和1980年标准的敏感性和特异性。
共招募了143例SSc患者和87例其他结缔组织病患者。弥漫性皮肤型SSc和局限性皮肤型SSc病例分别为41例(28.7%)和102例(71.3%)。虽然2013年标准的敏感性(94.4%)超过了1980年标准(72.7%)(P<0.001),但1980年和2013年标准集在特异性方面无显著差异(分别为97.7%和93.1%,P = 0.278)。与其他亚组相比,2013年标准在一些SSc亚组(如局限性皮肤型SSc、甲襞视频毛细血管镜检查[NVC]异常模式和雷诺现象[RP])中的敏感性显著高于1980年标准。
相对于1980年ACR标准,新的2013年ACR/EULAR标准在中国SSc患者中具有相似的特异性和更高的敏感性,尤其是对于皮肤增厚较轻或微血管疾病突出的患者。